Ulaner, G. A., Lyashchenko, S. K., Riedl, C., Ruan, S., Zanzonico, P. B., Lake, D., . . . O’Donoghue, J. A. (2018). First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using (89)Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer. J Nucl Med.
Citação norma ChicagoUlaner, Gary A., et al. "First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using (89)Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients With Breast Cancer." J Nucl Med 2018.
Citação norma MLAUlaner, Gary A., et al. "First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using (89)Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients With Breast Cancer." J Nucl Med 2018.